HomeCompany overviewLeadership teamStrategy Advisory BoardPartners & InstitutionsTherapeutic AreasTherapeutic ApproachInnovative Lipid VectorsPipelineGAO-3-02 / GAO-11-02NewsContact

Pipeline

Among its portfolio of active ingredients, GAOMA Therapeutics identified a first lead compound referred to as GAO-3-02.

Swipe left to explore